BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35116879)

  • 1. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.
    Li S; Ma Y; Xiong Y; Zhang P; Wang X; Wang Y; Yang Y
    Transl Cancer Res; 2019 Aug; 8(4):1364-1373. PubMed ID: 35116879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of autoantibody detection in the diagnosis and staging of lung cancer.
    Wang Y; Jiao Y; Ding CM; Sun WZ
    Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
    Ren Z; Ding HM; Qian X; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of seven autoantibodies in lung cancer diagnosis.
    Luo B; Mao G; Ma H; Chen S
    J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
    Chen P; Lu W; Chen T
    J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
    Li W; Sun Y; Xu N
    Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
    Mu Y; Xie F; Sun T
    J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
    Mu Y; Li J; Xie F; Xu L; Xu G
    J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
    Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of lung cancer by using an autoantibody panel in Chinese population.
    Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
    Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer.
    Xu Y; Zhang W; Xia T; Liu Y; Bi Z; Guo L; Xie W; Xiang Y; Xu Z; Yu Z; Li Y; Bai L
    Front Oncol; 2023; 13():1022331. PubMed ID: 36874112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.
    Wang A; Hao Y; Huo Y; Xu X; Zhang Y
    Front Oncol; 2024; 14():1358387. PubMed ID: 38800369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features.
    Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J
    Front Oncol; 2022; 12():883543. PubMed ID: 35530343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
    Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
    Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of an Enzyme-Linked Immunosorbent Assay for Seven Autoantibodies in Lung Cancer.
    Yin-Yu M; Fu-Yi X; Fei-Bo W; Ri-Yi Z; Xiao-Lin Y
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
    Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.